Ryan PB - Search Results

1

Managing data quality for a drug safety surveillance system.

Hartzema AG, Reich CG, Ryan PB, Stang PE, Madigan D, Welebob E, Overhage JM. Hartzema AG, et al. Among authors: ryan pb. Drug Saf. 2013 Oct;36 Suppl 1:S49-58. doi: 10.1007/s40264-013-0098-7. Drug Saf. 2013. PMID: 24166223

2

Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.

Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, Welebob E, Scarnecchia T, Woodcock J. Stang PE, et al. Among authors: ryan pb. Ann Intern Med. 2010 Nov 2;153(9):600-6. doi: 10.7326/0003-4819-153-9-201011020-00010. Ann Intern Med. 2010. PMID: 21041580

3

What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research.

Madigan D, Ryan P. Madigan D, et al. Epidemiology. 2011 Sep;22(5):629-31. doi: 10.1097/EDE.0b013e318228ca1d. Epidemiology. 2011. PMID: 21811110 No abstract available.

4

Disproportionality methods for pharmacovigilance in longitudinal observational databases.

Zorych I, Madigan D, Ryan P, Bate A. Zorych I, et al. Stat Methods Med Res. 2013 Feb;22(1):39-56. doi: 10.1177/0962280211403602. Epub 2011 Aug 30. Stat Methods Med Res. 2013. PMID: 21878461

5

Validation of a common data model for active safety surveillance research.

Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Overhage JM, et al. Among authors: ryan pb. J Am Med Inform Assoc. 2012 Jan-Feb;19(1):54-60. doi: 10.1136/amiajnl-2011-000376. Epub 2011 Oct 28. J Am Med Inform Assoc. 2012. PMID: 22037893 Free PMC article.

6

Novel data-mining methodologies for adverse drug event discovery and analysis.

Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Harpaz R, et al. Clin Pharmacol Ther. 2012 Jun;91(6):1010-21. doi: 10.1038/clpt.2012.50. Clin Pharmacol Ther. 2012. PMID: 22549283 Free PMC article. Review.

7

Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases.

Reich C, Ryan PB, Stang PE, Rocca M. Reich C, et al. Among authors: ryan pb. J Biomed Inform. 2012 Aug;45(4):689-96. doi: 10.1016/j.jbi.2012.05.002. Epub 2012 Jun 7. J Biomed Inform. 2012. PMID: 22683994 Free article.

8

Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.

Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Ryan PB, et al. Stat Med. 2012 Dec 30;31(30):4401-15. doi: 10.1002/sim.5620. Epub 2012 Sep 27. Stat Med. 2012. PMID: 23015364

9

Response to comment on 'empirical assessment of methods for risk identification in healthcare data'.

Ryan PB, Madigan D, Stang PE, Marc Overhage J, Racoosin JA, Hartzema AG. Ryan PB, et al. Stat Med. 2013 Mar 15;32(6):1075-7. doi: 10.1002/sim.5725. Stat Med. 2013. PMID: 23413215 No abstract available.

10

Evaluating the impact of database heterogeneity on observational study results.

Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W, Berlin JA. Madigan D, et al. Among authors: ryan pb. Am J Epidemiol. 2013 Aug 15;178(4):645-51. doi: 10.1093/aje/kwt010. Epub 2013 May 5. Am J Epidemiol. 2013. PMID: 23648805 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters